A community study of Drakshvaleha on Anaemia

A community-based study on the effectiveness and acceptance of Drakshavaleha for anaemia in selected districts of the Vidarbha region, Maharashtra

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100488

Enrollment

8300

Registered

2026-01-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D649- Anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: i) Individuals of any gender, age above 18 years ii) Hb 8-11.9 in women and 8-12.9 in men iii) Willing to take the Ayurveda intervention for 3 months

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. Known cases of Diabetes mellitus 3. Known cases of any Hemoglobinopathies, bleeding disorders, serious systemic illnesses like malignancy, 4. Individuals having a family history of hemoglobinopathies and history of blood transfusion in the last 6 months

Design outcomes

Primary

Measure	Time frame
Change in mean haemoglobin levels from baseline to the end of 12th weeksTimepoint: At the end of 12th weeks	—

Secondary

Measure	Time frame
Change in mean score of the FACIT-Fatigue Scale from baseline to the end of 12 weeksTimepoint: At the end of 12th weeks;Proportion of participants showing treatment adherence equal to and more than 70%Timepoint: At the end of 4th,8th & 12th weeks;Participant satisfaction with intervention (measured through end-line interview)Timepoint: At the end of 12th weeks;Proportion of men with Hb gm% equal or more than 13 and women with Hb gm % equal or more than 12 after three months of Ayurveda interventionTimepoint: At the end of 12th weeks	—

Measure

Time frame

Change in mean score of the FACIT-Fatigue Scale from baseline to the end of 12 weeksTimepoint: At the end of 12th weeks;Proportion of participants showing treatment adherence equal to and more than 70%Timepoint: At the end of 4th,8th & 12th weeks;Participant satisfaction with intervention (measured through end-line interview)Timepoint: At the end of 12th weeks;Proportion of men with Hb gm% equal or more than 13 and women with Hb gm % equal or more than 12 after three months of Ayurveda interventionTimepoint: At the end of 12th weeks

—

Countries

India

Contacts

Public ContactDr Kalpana Kachare

Central Council for Research in Ayurvedic Sciences

kachare.kalpana@gmail.com09834410028

Outcome results